Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were some of the confirmed speakers for Cell 2023

Senior Research Scientist
AstraZeneca
Chief Executive Officer & Director
Roquefort Therapeutics PLC (LON: ROQ) & Celixir
Don Panoz Chair of Pharmaceutical Biology & Principal Investigator
Trinity College Dublin & National Institute for Bioprocessing Research & Training
National Senior Programme of Care Manager (Innovative Treatments)
NHS England
Director of Manufacturing
InMune Bio
Professor of Development Neurobiology, Psychology & Neuroscience, & Group Leader
Kings College London & Francis Crick Institute
Professor of Stem Cell Biology and Regenerative Medicine
University of Reading
CMC Product Lead
Orchard Therapeutics
Director, Process & Analytical Development
Orchard Therapeutics
Head Manufacturing Science & Technology
Tigen Pharma
Senior Production Scientist
Guy’s & St Thomas’ NHS Foundation Trust
Principal Scientist
Bristol Myers Squibb
Director, Molecular Development
MeriaGTx
Professor of Sustainable Manufacturing Systems
Kings College London
Chief Scientific Officer
Cell Prothera
Artificial Intelligence Scientist
AstraZeneca
Head of GMP Production, Chief Scientific Officer and Co-Founder
Muvon Therapeutics
Head of Chemical and Bioprocess Engineering School & Assistant Professor
University College Dublin
Chief Scientific Officer
Adaptimmune
Vice President & Head of Translational Medicine
Cargo Therapeutics
Head of Therapeutic Virus Development
Boehringer Ingelheim
Chief Scientific Officer
a:head bio
Senior Stem Cell Biologist
Medicines and Healthcare products Regulatory Agency
Senior Scientist
AstraZeneca
Head of the UK Stem Cell Bank
Medical Healthcare and Research Products Agency
Vice-President, Professor of Chemical and Biochemical Engineering, FCT-UNL
iBET
Team Leader
Ichnos Sciences
Chief Scientific Officer and Co-Founder
InMuneBio
Principal Scientist & Team Leader
Quell Therapeutics
Head of Process Transfer Cell Culture
Boehringer Ingelheim
Associate Director, Science & Technology
Novartis
Head of Cell Line Development
Philogen
Senior Scientist, Cell Line Development & Engineering
REGENXBIO
Research Scientist
AstraZeneca
Vice President Operations
Complement Therapeutics
Head of Process Development, Centre for Gene Therapy and Regenerative Medicine
Kings College London
Senior Scientist
INmune Bio
Head, Translational Research Group, Translational Research Office
University College London
Chief Scientific Officer International Therapeutics Research Centers, Founder
Moderna Rare Diseases
Professor Of Regenerative Biology & Principal Investigator
University College London
Associate Director, Vector Process Development
Orchard Therapeutics
Chairman of the Advisory Board, Scientific Counsellor
CellProthera
Chief Technology Officer
SmartImmune
Group Leader - Cell Biology
ReNeuron
Head of Laboratory – Cell Biology
Boehringer Ingelheim
Professor & Head of Biotechnology Group
University of Leicester
Global regCMC Director Cell and Gene Therapy
Novartis
Senior Lecturer, Innate Immunity and Regenerative Medicine
King's College London
Principal Scientist
Plasticell
Chief Technology Officer
Rinri Therapeutics
Director, Head of Development Core Technologies, Viral Therapeutics Centre
Boehringer Ingelheim
Head of Launch Preparation and Coordination
Bayer AG
Senior Advisor Biopharmaceuticals
Boehringer Ingelheim
Senior Scientist
MeriaGTx
Chief Development Officer
Glycostem
Principal Scientist
Ipsen